Bedaquiline Fumarate + Mao Inhibitors Interaction
Majorinteraction on record
Description
Coadministration increases systemic exposure of bedaquiline, which may increase risk of adverse reactions. Closely monitor patient safety and liver function.
Mechanism
CYP3A4 enzyme inhibition increases bedaquiline systemic exposure
Source: NLP:bedaquiline fumarate